Skip to main content

Holbrook Kerr's Form 4 filing

Avanos Medical, Inc.AVNS · filed Nov 19, 2025

Accession no.
0001606498-25-000133
Filed
Nov 19, 2025
Trade date
Nov 18, 2025
Filing delay
1 day
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions. Open-market sales total $165.0K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Holbrook KerrCIK 0001861246Officer (SVP, Chief Commercial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 18, 2025Common StockSSaleDisposed−13,834$11.00−$152,17485,026Direct
Nov 18, 2025Common StockSSaleDisposed−100$11.01−$1,10184,926Direct
Nov 18, 2025Common StockSSaleDisposed−761$11.01−$8,378.6184,165Direct
Nov 18, 2025Common StockSSaleDisposed−305$11.02−$3,361.183,860Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)